Moritz Hamann
Overview
Explore the profile of Moritz Hamann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamann M, Bensmann E, Andrulat A, Festl J, Saadat G, Klein E, et al.
Arch Gynecol Obstet
. 2024 Nov;
310(6):3077-3089.
PMID: 39505750
Purpose: To analyze complications and potential risk factors associated with immediate prepectoral direct-to-implant breast reconstruction (DTIBR). Methods: 295 patients (326 operated breasts) with DTIBR between March 2021 and December 2023...
2.
Braun M, Kriegmair A, Szeterlak N, Andrulat A, Schrodi S, Kriner M, et al.
Breast Care (Basel)
. 2022 Aug;
17(3):288-295.
PMID: 35957951
Introduction: The aim of the present study was to analyze the performance of Oncotype DX® multigene assay (ODX®) in patients with 0-3 lymph nodes in a high-volume community hospital. Methods:...
3.
Napieralski R, Schricker G, Auer G, Aubele M, Perkins J, Magdolen V, et al.
Breast Care (Basel)
. 2021 Nov;
16(5):523-531.
PMID: 34720812
Background: PITX2 DNA methylation has been shown to predict outcomes in high-risk breast cancer patients after anthracycline-based chemotherapy. To determine its prognostic versus predictive value, the impact of PITX2 DNA...
4.
Stoetzer O, Di Gioia D, Issels R, Abdel-Rahman S, Mansmann U, Lindner L, et al.
Breast Care (Basel)
. 2021 May;
16(2):173-180.
PMID: 34012372
Background: Patients with triple-negative primary breast cancer (TNBC) who have residual invasive carcinoma after neoadjuvant chemotherapy have poor prognosis. Proven adjuvant approaches to reduce the risk of recurrence and improve...
5.
Van den Heerik A, Horeweg N, Nout R, Lutgens L, van der Steen-Banasik E, Westerveld G, et al.
Int J Gynecol Cancer
. 2020 Oct;
30(12):2002-2007.
PMID: 33046573
Background: Vaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited...
6.
Hamann M, Grill S, Struck J, Bergmann A, Hartmann O, Polcher M, et al.
Biomark Med
. 2019 Aug;
13(13):1107-1117.
PMID: 31468986
We assessed the suitability of a biomarker panel to improve early detection and individual risk assessment in breast cancer (BC) patients. PENK, pro-SP, hGH and CA15-3 of 204 BC patients...
7.
Hamann M, Brunnbauer M, Scheithauer H, Hamann U, Braun M, Polcher M
Arch Gynecol Obstet
. 2019 May;
300(2):409-420.
PMID: 31144025
Objectives: The purpose of this study was to analyze the effects of prior radiotherapy (RT) as well as postmastectomy radiotherapy (PMRT) on patient-reported quality of life (QoL) and on surgical/aesthetic...
8.
Ortiz J, Hammerl T, Wasmaier M, Wienerroither V, Haller B, Hamann M, et al.
Geburtshilfe Frauenheilkd
. 2019 Apr;
79(4):389-395.
PMID: 31000884
Various methods of intrapartum analgesia are available these days. Pethidine, meptazinol and epidural analgesia are among the most commonly used techniques. A relatively new one is patient-controlled intravenous analgesia with...
9.
Schneider S, Beckinger V, Moller B, Knupfer S, Hamann M, Deuschl G
J Neurol
. 2018 Nov;
266(1):207-211.
PMID: 30467602
Background: Urinary involvement is common in hereditary spastic paraplegias (HSPs), but has rarely been assessed systematically. Methods: We characterized urinary complaints in 71 German HSP patients (mean age 55.4 ± ...
10.
Brugger S, Hamann M, Mosner M, Beer M, Braun M, Polcher M
World J Surg Oncol
. 2018 May;
16(1):95.
PMID: 29773071
Background: Sentinel lymph node dissection (SLND) may reduce morbidity in patients with endometrial cancer. The objective of this study is to estimate how many systematic lymph node dissections (LND) can...